[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:t-lymphocyte":3},{"name":4,"total":5,"recruiting":5,"trials":6},"T-lymphocyte",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03801434","Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders",[11],"Phase 2","RECRUITING","2026-08-26T02:17:22.949982Z","2026-05-05T02:43:27.944996Z"]